Majority Of Biopharma Firms In China Enjoy Net Profit Growth In 2010
This article was originally published in PharmAsia News
Executive Summary
Roughly 61 of the 87 Chinese pharmaceutical companies disclosed their performance forecasts for 2010 with an estimated growth of 25 to 30 percent on average in net profits, and 43 companies predicted an increase of over 30 percent, according to financial analysis company Wind's statistics Jan. 30